The Helmholtz International Graduate School for Cancer Research in Heidelberg is the interdisciplinary and international PhD program for all students working at the German Cancer Research Center (DKFZ). Our PhD students conduct research at the forefront of basic, computational, epidemiological and translational cancer research.
We warmly invite you to apply to the DKFZ and join our many distinguished scientists in cancer research!
The next application deadline is 31st May 2017!
How to Apply
The first stage of the application process takes place online. There are two application rounds each year. The deadlines are 5th January and 31st May of each year.
The next application deadlines are:
- 31st May 2017 for the 2017 Summer Selection
(Interviews from 25th – 27th July 2017, by invitation only)
- 5th January 2018 for the 2018 Winter Selection
(Interviews from 27th Feb – 1st Mar 2018, by invitation only)
Please apply using our Online Application System (the system will open approx. two months before the next application deadline).
In the application form, you ar asked to provide information about your educational qualifications, honors, skills and interests. A statement of motivation is also required and letters of recommendation from two referees. When filling in the online form, remember to have electronic copies (PDF files of not more than 3MB) of your academic certificates and English language certificate to upload with your application.
Please don't forget to click the submit button once you have completed the online application form. Your letters of recommendation do NOT already have to be submitted by your referees in order for you to submit your application.
The DKFZ is Germany’s largest biomedical research institute and has an international and dynamic work environment, providing students with access to state-of-the-art research facilities and exceptional resources. More than 500 PhD students in over 100 divisions and research groups carry out research to unravel the causes and mechanisms of cancer development and to identify novel tools for diagnosis, treatment and prevention.
For more information please click "Further Official Information" below.
This opportunity has expired. It was originally published here: